Optimized MRI of Patients With Hip Arthroplasty
ConditionHip Arthropathy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorNYU Langone Health
About this trial
This is a single-center single-arm clinical trial with a paired design which compares the effectiveness of 3T MRI with (modified) and without (standard) radiofrequency pulse polarization optimization in reducing metal-related artifacts in patients with hip arthroplasty implants.
Eligibility criteria
Qualifiers
Patients aged ≥ 18 with unilateral symptomatic (e.g. pain) total hip arthroplasty
Referred for MRI examination at the discretion of the treating physician
Provision of signed and dated informed consent form
No metal hardware in the body including contralateral hip arthroplasty
Disqualifiers
History of revision hip arthroplasty
Pregnancy (self-reported, or self-suspected)
Hip arthroplasty surgery within one year of enrollment
Clinical indication to administer intravenous contrast material during MRI
Trial design
Treatments tested in this trial
- Modified MRI
Treatment groups
22 Participants
are divided into 1 treatment groupSponsors and collaborators
NYU Langone Health
Lead sponsor
Radiological Society of North America
Collaborator
ISS, Inc.
Collaborator
Source ClinicalTrials.gov